Corporate Announcement
Security Code : 532523    Company : BIOCON    
 
Mylan and Biocon Announce U.S. FDA Submission for Proposed Biosimilar TrastuzumabDownload PDF
  Exchange Disseminated Time     08/11/2016 17:52:27
Biocon Ltd has informed BSE regarding a Press Release dated November 08, 2016 titled "Mylan and Biocon Announce U.S. FDA Submission for Proposed Biosimilar Trastuzumab".
 

Disclaimer
Back To Announcements